Singapore HSA registration DE0510228
BD Anti-HLA-DR (L243)
Device classification
- Device Class
- CLASS C IVD
- Medical Speciality Area
- Clinical chemistry
Registration information
- Registration Number
- DE0510228
- Registration Date
- January 09, 2025
- Retention Due Date
- January 08, 2026
Product description
Anti–HLA-DR (L243) is intended for in vitro diagnostic use in the identification of cells expressing the HLA- DR antigen in peripheral blood, using a BD FACSLyric™ flow cytometer. Clinical Applications: Expression of the HLA-DR antigen in the characterization of subjects having, or suspected of having, hematological neoplasia. Anti–HLA-DR (L243) is a qualitative reagent intended for laboratory professional use only
Product Owner
- Short Name
- Becton, Dickinson & Company
- Address
- Becton, Dickinson and Company, BD Biosciences, 155 North McCarthy Boulevard, Milpitas, California 95035, UNITED STATES
Registrant
- Address
- 10 COLLYER QUAY, OCEAN FINANCIAL CENTRE, #10-01, SINGAPORE 049315
Importer
- Address
- 10 COLLYER QUAY, OCEAN FINANCIAL CENTRE, #10-01, SINGAPORE 049315
Model information
- Model Name(s)
- BD Anti–HLA-DR (L243) PE-Cy7 BD Anti–HLA-DR (L243) PerCP-Cy5.5 BD Anti–HLA-DR (L243) V450
- Model Identifier(s)
- 335830 339216 655874
About this record
Access comprehensive regulatory information for BD Anti-HLA-DR (L243) in the Singapore medical device market through Pure Global AI's free database. This CLASS C IVD medical device is registered under HSA registration number DE0510228 and owned by Becton, Dickinson & Company. The device was registered on January 09, 2025.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
Free DatabasePowered by Pure Global AIHSA Official DataCLASS C IVD